Corinth MedTech
Founded Year
2014Stage
Loan | AliveTotal Raised
$17MLast Raised
$5M | 2 yrs agoAbout Corinth MedTech
Corinth MedTech has developed a bipolar transurethral and transcervical resection system intended for endoscopically controlled tissue removal for male patients diagnosed with benign prostatic hyperplasia (BPH), and female patients diagnosed with Abnormal Uterine Bleeding (AUB), fibroids and/or polyps requiring Hysteroscopic tissue removal.
Missing: Corinth MedTech's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Corinth MedTech's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Corinth MedTech
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Corinth MedTech is included in 3 Expert Collections, including Medical Devices.
Medical Devices
11,721 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Women's Health & Wellness
1,487 items
Startups focused on providing products and services catering to women's health and wellbeing.
Health IT
7,901 items
Corinth MedTech Patents
Corinth MedTech has filed 7 patents.
The 3 most popular patent topics include:
- Male genital surgery
- Antiandrogens
- Prostate cancer
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/29/2019 | 9/20/2022 | Endoscopy, Medical equipment, Male genital surgery, Prostatic procedures, Prostate cancer | Grant |
Application Date | 1/29/2019 |
|---|---|
Grant Date | 9/20/2022 |
Title | |
Related Topics | Endoscopy, Medical equipment, Male genital surgery, Prostatic procedures, Prostate cancer |
Status | Grant |
Latest Corinth MedTech News
Jan 5, 2021
Corinth MedTech, Inc. , a San Jose, California-based medical device company that develops, manufactures and markets urological device solutions, received a $5M venture loan from Horizon Technology Finance Corporation (NASDAQ: HRZN). The company will use the loan proceeds for general working capital purposes. Led by Steve Duddy, President and Chief Executive Officer, Corinth MedTech has developed the Veloxion™ System, an FDA-cleared device for treating symptoms related to Benign Prostatic Hyperplasia (BPH), more commonly known as TURP for enlarged prostate. The Veloxion™ System includes a single-use resectoscope with integrated camera, a light source and a complete fluid management system for TURP and TURBT (removal of bladder tumors) procedures, allowing physicians to perform tissue resections for their patients. The system is cleared for use in treating the symptoms of Benign Prostatic Hyperplasia (BPH) and Bladder Tumors, and its commercial launch is slated for 2021. FinSMEs
Corinth MedTech Frequently Asked Questions (FAQ)
When was Corinth MedTech founded?
Corinth MedTech was founded in 2014.
Where is Corinth MedTech's headquarters?
Corinth MedTech's headquarters is located at 1601 S. De Anza Blvd., Cupertino.
What is Corinth MedTech's latest funding round?
Corinth MedTech's latest funding round is Loan.
How much did Corinth MedTech raise?
Corinth MedTech raised a total of $17M.
Who are the investors of Corinth MedTech?
Investors of Corinth MedTech include Horizon Technology Finance, Shangbay Capital and Aethan Capital.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.